|
2007E-0002:
Patent Extension Application for ELAPRASE (idursulfase), U.S. Patent
No. 5,932,211
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| APP1
|
| 01/03/2007
|
| 01/03/2007
|
| Private Industry
|
| Women's and Children's
Hospital
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Michael T. Siekman
|
|
|
|
|
| LET1
|
| 01/03/2007
|
| 01/03/2007
|
| Federal Government
|
| U.S. Patent &
Trademark Office to Wolf, Greenfield & Sacks, P.C.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Mary C. Till
|
|
|
|
|
| LET2
|
| 01/03/2007
|
| 01/03/2007
|
| Federal Government
|
| U.S. Patent &
Trademark Office to FDA/CDER (HFD-7)
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Mary C. Till
|
|
|
|
|
| LET3
|
| 02/08/2007
|
| 02/08/2007
|
| Federal Government
|
| FDA/CDER to the U.S.
Patent and Trademark Office
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Jane A. Axelrad
| |
|
|
Top
| Up
Page last updated:
March 29, 2007
|
